Stelios Papadopoulos - Nov 30, 2021 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Role
Director
Signature
Christopher Aker, Attorney in Fact
Stock symbol
RGLS
Transactions as of
Nov 30, 2021
Transactions value $
$800,000
Form type
4
Date filed
12/1/2021, 03:12 PM
Previous filing
Jul 2, 2021
Next filing
Feb 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGLS Common Stock Award $800K +2.22M +78.26% $0.36 5.06M Nov 30, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.